Survey of Scottish Dermatological Society members on the new Medicines and Healthcare products Regulatory Agency isotretinoin recommendations

Author:

Dubash Faisal1ORCID,Dawe Robert2,Affleck Andrew1ORCID

Affiliation:

1. Department of Dermatology, Ninewells Hospital and Medical School , Dundee , UK

2. Photobiology Unit, NHS Tayside , Dundee , UK

Abstract

Recent Medicines and Healthcare products Regulatory Agency (MHRA) isotretinoin legislation includes significant changes that will affect clinical practice for dermatologists across the UK. We obtained opinions from members of the Scottish Dermatological Society on these recommendations. The survey yielded an adequate number of responses with significant results and free-text comments of interest to practising UK dermatologists. Overall responses from SDS members highlighted many concerns with the MHRA guidance and its impact on patient care. The results of this survey question the credibility of the MHRA. We propose the creation of an objective working group, with no conflicts of interest.

Publisher

Oxford University Press (OUP)

Reference5 articles.

1. Drug safety update. Isotretinoin (Roaccutane): new safety measures to be introduced in the coming months, including additional oversight on initiation of treatment for patients under 18 years;Medicines and Healthcare products Regulatory Agency (MHRA)

2. Isotretinoin exposure does not appear to be associated with risk of adverse male sexual health outcomes in acne patients;Thang;Int J Dermatol,2024

3. Risk of suicide and psychiatric disorders among isotretinoin users, a meta-analysis;Tan;JAMA Dermatol,2024

4. Burden of proof – critical flaws in the recommendations from the commission on human medicines Isotretinoin expert working group;Tan;Australas J Dermatol,2023

5. The postmodern assault on science. If all truths are equal, who cares what science has to say?;Kuntz;EMBO Rep,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3